Conclusion Hitting a weight loss plateau while on GLP-1 medications is more common than you might think
Proposed risk factors include a change in bile acid production and secretion, suppressed cholecystokinin secretion, decreased emptying time, prolonged gallbladder refilling, and weight loss
Injectable use presents more unknowns
Gina Roberts used to have this recurring nightmare: frantic and broke, she would search everywhere for a drink, but always the alcohol would remain out of reach
Genetic predispositions in these peptide pathways do not predict exact medication response or travel tolerability, but they can support a conversation with your provider about whether your current therapy formulation and dosing strategy aligns with your individual metabolic profile during routine conditionsand therefore how that might shift under travel stress
Every serious complication in trials involved dehydration